# Ciprofloxacin in Drug-resistant Epilepsy

> **NCT04763070** · NA · COMPLETED · sponsor: **Mazandaran University of Medical Sciences** · enrollment: 23 (actual)

## Conditions studied

- Epilepsy Intractable

## Interventions

- **DRUG:** Ciprofloxacin Oral Product

## Key facts

- **NCT ID:** NCT04763070
- **Lead sponsor:** Mazandaran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04763070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04763070, "Ciprofloxacin in Drug-resistant Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04763070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*